Shedding of porcine circovirus type 1 DNA and rotavirus RNA by infants vaccinated with Rotarix® mijatovicrustempasic2017shedding

This study investigated the shedding of porcine circovirus type 1 (PCV-1) DNA and Rotavirus group A (RVA) RNA in 33 infants aged approximately 2 months following the first dose of Rotarix® vaccine. Stool samples were collected serially post-vaccination and analyzed using molecular methods. The study found that 21% of infants did not shed RVA RNA beyond day 3, suggesting a lack of vaccine virus replication in some cases. The study was conducted in Atlanta, Georgia, and involved both full-term and preterm infants. The analysis used quantitative real-time RT-PCR and qPCR assays to detect viral RNA and DNA in stool samples.

Analytes

stool_rotavirus_vaccine

Detection of Rotarix® Rotavirus group A RNA in stool samples post-vaccination using qRT-PCR targeting the NSP3 gene of RVA.

Biomarker: rotavirus vaccine
Specimen: stool
Units: gc/mL
Gene target: NSP3
Participants: 33
Negative samples: 113
Positive samples (not quantifiable): 0
Quantifiable samples: 155
Limit of quantification: unknown
Limit of detection: unknown

stool_pcv1_dna

Detection of Rotarix® PCV-1 DNA in stool samples post-vaccination using qPCR.

Biomarker: rotavirus vaccine
Specimen: stool
Units: gc/mL
Participants: 33
Negative samples: 226
Positive samples (not quantifiable): 0
Quantifiable samples: 43
Limit of quantification: unknown
Limit of detection: unknown